Airway diseases
Poster discussion
Integrating pharmacological and non-pharmacological management in COPD: are we there yet?
Methods :
General respiratory patient care, Epidemiology, Public health, Cell and molecular biology
Late Breaking Abstract - A randomized clinical study to assess the impact of budesonide/formoterol (BUD/FM) pMDI medication reminders on adherence in COPD patients
G. Criner(Philadelphia, United States)
COI
1
Evaluation of safety, tolerability, pharmacokinetics, and food effect of Danirixin oral tablets in Japanese elderly healthy subjects
Y. Matsuzawa(Tokyo, Japan)
COI
2
Population health impact of Indacaterol/Glycopyrronium over 4 years in chronic obstructive pulmonary disease
F. Gutzwiller(Basel, Switzerland)
COI
3
Risk of exacerbation and pneumonia with single inhaler triple versus dual therapy in IMPACT
M. Dransfield(Birmingham, United States)
COI
4
Eosinophils as a predictor of mepolizumab treatment responses in COPD
I. Pavord(Oxford (Oxfordshire), United Kingdom)
COI
5
Reduced glucocorticoid receptor binding affinity in blood lymphocytes and monocytes of COPD patients
A. Tahanovich(Minsk, Belarus)
COI
6
Real-life data on COPD treatment
L. Karimi(Rotterdam, Netherlands)
COI
7
Personalized treatment through an inhaler device, adjustable to patient's respiratory profile
K. Zarogoulidis(Thessaloniki, Greece)
COI
8
Single inhaler triple therapy in patients with COPD: patient-reported dyspnoea and health status from the IMPACT Trial
M. Tabberer(Uxbridge (Middlesex), United Kingdom)
COI
9
FACTORS INFLUENCING PHARMACOLOGICAL TREATMENT IN COPD PATIENTS ENROLED IN AN INTEGRATED DISEASE MANAGEMENT PROGRAMME (IDMP)
M. Moretti(Modena (MO), Italy)
COI
10
Can a telemonitoring system lead to decreased hospital admissions in elderly patients?
J. Lyth(Linköping, Sweden)
COI
11
An evaluation of ‘care bundles’ as a means of improving hospital care for patients with COPD: results of a multi-centre study in the UK
J. Calvert(Caerleon, United Kingdom)
COI
12
Implementation of an integrated care pathway based in a population health approach in Bilbao for Chronic Obstructive Pulmonary Disease patients
M. Martínez Vázquez(Bilbao (Bizkaia), Spain)
COI
13
Cost-effectiveness analysis of a Home-based disease management intervention for patients with severe COPD alongside the COMET study.
D. GRANADOS(Gentilly, France)
COI
14
Clinical management of patients newly diagnosed with COPD through targeted case finding and routine care: a longitudinal analysis of the TargetCOPD trial
S. Haroon(Birmingham (West Midlands), United Kingdom)
COI
15
Healthcare resource consumption in Italian patients with COPD: The MISTRAL study
P. Morini(Imola (BO), Italy)
COI
16
Comparison of Clinical Efficacy and Safety between ultraLABAs and ultraLAMAs in Patients with COPD: A Systemic Review with a Meta-Analysis of Randomized Controlled Trials
E. CHO(Seoul, Republic of Korea)
COI
17
Generating patient insights in chronic obstructive pulmonary disease (COPD) with social media listening study
F. Gutzwiller(Basel, Switzerland)
COI
18
. . .
